메뉴 건너뛰기




Volumn 103, Issue 6, 1997, Pages 483-490

Efficacy of 24-week monotherapy with acarbose, metformin, or placebo in dietary-treated NIDDM patients: The essen-II study

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN;

EID: 0031460261     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(97)00252-0     Document Type: Article
Times cited : (150)

References (46)
  • 1
    • 0023972830 scopus 로고
    • Acarbose, a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential
    • Clissold SP, Edwards C. Acarbose, a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs. 35:1988;214-243.
    • (1988) Drugs. , vol.35 , pp. 214-243
    • Clissold, S.P.1    Edwards, C.2
  • 2
    • 0029133235 scopus 로고
    • Metabolic effects of metformin in non-insulin-dependent diabetes mellitus
    • Stumvoll M, Nurjhan N, Perriello G, et al. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. NEJM. 333:1995;550-554.
    • (1995) NEJM. , vol.333 , pp. 550-554
    • Stumvoll, M.1    Nurjhan, N.2    Perriello, G.3
  • 3
    • 0025823825 scopus 로고
    • Therapeutic potentials of acarbose as first-line drug in NIDDM insufficiently treated with diet alone
    • Hanefeld M, Fischer S, Schulze J, et al. Therapeutic potentials of acarbose as first-line drug in NIDDM insufficiently treated with diet alone. Diabetes Care. 14:1991;732-737.
    • (1991) Diabetes Care. , vol.14 , pp. 732-737
    • Hanefeld, M.1    Fischer, S.2    Schulze, J.3
  • 4
    • 0028357199 scopus 로고
    • Efficacy of 24-week monotherapy with acarbose, glibenclamide or placebo in NIDDM patients. The Essen Study
    • Hoffmann J, Spengler M. Efficacy of 24-week monotherapy with acarbose, glibenclamide or placebo in NIDDM patients. The Essen Study. Diabetes Care. 17:1994;561-566.
    • (1994) Diabetes Care. , vol.17 , pp. 561-566
    • Hoffmann, J.1    Spengler, M.2
  • 5
    • 0027947449 scopus 로고
    • The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus
    • Chiasson J-L, Josse RG, Hunt JA, et al. The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. Ann Intern Med. 121:1994;928-935.
    • (1994) Ann Intern Med. , vol.121 , pp. 928-935
    • Chiasson J-L1    Josse, R.G.2    Hunt, J.A.3
  • 6
    • 0029064970 scopus 로고
    • Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus
    • Coniff RF, Shapiro JA, Seaton TB, Bray GA. Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus. Am J Med. 98:1995;443-451.
    • (1995) Am J Med. , vol.98 , pp. 443-451
    • Coniff, R.F.1    Shapiro, J.A.2    Seaton, T.B.3    Bray, G.A.4
  • 7
    • 0029044690 scopus 로고
    • Reduction of glycosylated hemoglobin and postprandial hyperglycemia by acarbose in patients with NIDDM. A placebo-controlled dose-comparison study
    • Coniff RF, Shapiro JA, Robbins D, et al. Reduction of glycosylated hemoglobin and postprandial hyperglycemia by acarbose in patients with NIDDM. A placebo-controlled dose-comparison study. Diabetes Care. 18:1995;817-824.
    • (1995) Diabetes Care. , vol.18 , pp. 817-824
    • Coniff, R.F.1    Shapiro, J.A.2    Robbins, D.3
  • 8
    • 0027935577 scopus 로고
    • Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study
    • Hermann LS, Scherstén B, Bitzén P-O, et al. Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study. Diabetes Care. 17:1994;1100-1109.
    • (1994) Diabetes Care. , vol.17 , pp. 1100-1109
    • Hermann, L.S.1    Scherstén, B.2    Bitzén P-O3
  • 9
    • 0029099086 scopus 로고
    • Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus
    • DeFronzo RA, Goodmann AM. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. NEJM. 333:1995;541-549.
    • (1995) NEJM. , vol.333 , pp. 541-549
    • Defronzo, R.A.1    Goodmann, A.M.2
  • 10
    • 0029587420 scopus 로고
    • The use of acarbose in the primary-care setting: Evaluation of efficacy and tolerability of acarbose by postmarketing surveillance study
    • Spengler M, Cagatay M. The use of acarbose in the primary-care setting: evaluation of efficacy and tolerability of acarbose by postmarketing surveillance study. Clin Invest Med. 18:1995;325-331.
    • (1995) Clin Invest Med. , vol.18 , pp. 325-331
    • Spengler, M.1    Cagatay, M.2
  • 11
    • 0345284828 scopus 로고
    • Comparison of acarbose and metformin treatment in non-insulin-dependent diabetic out-patients
    • W. Creutzfeld. Amsterdam: Excerpta Medica
    • Schwedes U, Petzoldt R, Hillebrand I, Schöffling K. Comparison of acarbose and metformin treatment in non-insulin-dependent diabetic out-patients. Creutzfeld W. First International Symposium on Acarbose. 1982;275-281 Excerpta Medica, Amsterdam.
    • (1982) First International Symposium on Acarbose , pp. 275-281
    • Schwedes, U.1    Petzoldt, R.2    Hillebrand, I.3    Schöffling, K.4
  • 12
    • 0030070954 scopus 로고    scopus 로고
    • A comparison of acarbose versus metformin as an adjuvant therapy in sulfonylurea-treated NIDDM patients
    • Bayraktar M, Adalar N, Van Thiel DH. A comparison of acarbose versus metformin as an adjuvant therapy in sulfonylurea-treated NIDDM patients. Diabetes Care. 19:1996;252-254.
    • (1996) Diabetes Care. , vol.19 , pp. 252-254
    • Bayraktar, M.1    Adalar, N.2    Van Thiel, D.H.3
  • 13
    • 0015348189 scopus 로고
    • Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultra centrifuge
    • Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultra centrifuge. Clin Chem. 18:1972;499-502.
    • (1972) Clin Chem. , vol.18 , pp. 499-502
    • Friedewald, W.T.1    Levy, R.I.2    Frederickson, D.S.3
  • 15
    • 0003312934 scopus 로고
    • Non-insulin-dependent Diabetes Mellitus (NIDDM)
    • Sydney: Health Communication Australia Pty Limited
    • Baba S, Zimmet P. Non-insulin-dependent Diabetes Mellitus (NIDDM). Practical Targets and Treatments. 1995;Health Communication Australia Pty Limited, Sydney.
    • (1995) Practical Targets and Treatments
    • Baba, S.1    Zimmet, P.2
  • 16
    • 0028874605 scopus 로고
    • Consensus statement: The pharmacological treatment of hyperglycemia in NIDDM
    • Consensus statement: The pharmacological treatment of hyperglycemia in NIDDM. Diabetes Care. 18:1995;1510-1518.
    • (1995) Diabetes Care. , vol.18 , pp. 1510-1518
  • 17
    • 0024519649 scopus 로고
    • Metformin improves peripheral but not hepatic insulin action in obese patients with type II diabetes
    • Hother-Nielsen O, Schmitz O, Andersen PH. Metformin improves peripheral but not hepatic insulin action in obese patients with type II diabetes. Acta Endocrinol. 120:1989;257-265.
    • (1989) Acta Endocrinol. , vol.120 , pp. 257-265
    • Hother-Nielsen, O.1    Schmitz, O.2    Andersen, P.H.3
  • 18
    • 0345716476 scopus 로고
    • Metformin improves insulin sensitivity in insulin-resistant normoglycemic relatives of patients with non-insulin-dependent diabetes mellitus
    • Eriksson J, Widén E, Saloranta C. Metformin improves insulin sensitivity in insulin-resistant normoglycemic relatives of patients with non-insulin-dependent diabetes mellitus. Diabetes. 39:(suppl 1):1990;109A.
    • (1990) Diabetes. , vol.39 , Issue.SUPPL. 1
    • Eriksson, J.1    Widén, E.2    Saloranta, C.3
  • 19
    • 0027495982 scopus 로고
    • The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetic patients
    • Johnson AB, Webster JM, Sum C-F, et al. The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetic patients. Metabolism. 42:1993;1217-1222.
    • (1993) Metabolism , vol.42 , pp. 1217-1222
    • Johnson, A.B.1    Webster, J.M.2    Sum C-F3
  • 20
    • 0027399661 scopus 로고
    • Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects
    • Nagi DK, Yudkin JS. Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. Diabetes Care. 16:1993;621-629.
    • (1993) Diabetes Care. , vol.16 , pp. 621-629
    • Nagi, D.K.1    Yudkin, J.S.2
  • 21
    • 0344853459 scopus 로고
    • Can we prevent the development of non-insulin-dependent diabetes mellitus?
    • Chiasson J-L, Josse RG, Leiter LA, et al. Can we prevent the development of non-insulin-dependent diabetes mellitus? Diabetes. 43:(suppl 1):1994;62A.
    • (1994) Diabetes. , vol.43 , Issue.SUPPL. 1
    • Chiasson J-L1    Josse, R.G.2    Leiter, L.A.3
  • 22
    • 0025780331 scopus 로고
    • Hyperinsulinemia: The key feature of a cardiovascular and metabolic syndrome
    • Ferrannini E, Haffner SM, Mitchell BD, Stern MP. Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia. 34:1991;416-422.
    • (1991) Diabetologia. , vol.34 , pp. 416-422
    • Ferrannini, E.1    Haffner, S.M.2    Mitchell, B.D.3    Stern, M.P.4
  • 23
    • 0025790941 scopus 로고
    • Insulin and cardiovascular disease. Paris Prospective Study
    • Fontbonne AM, Eschwège EM. Insulin and cardiovascular disease. Paris Prospective Study. Diabetes Care. 14:1991;461-469.
    • (1991) Diabetes Care. , vol.14 , pp. 461-469
    • Fontbonne, A.M.1    Eschwège, E.M.2
  • 24
    • 0027250501 scopus 로고
    • Risk factors for early death in non-insulin-dependent diabetes and men with known glucose tolerance status
    • Balkau B, Eschwège E, Papoz L, et al. Risk factors for early death in non-insulin-dependent diabetes and men with known glucose tolerance status. BMJ. 307:1993;295-299.
    • (1993) BMJ. , vol.307 , pp. 295-299
    • Balkau, B.1    Eschwège, E.2    Papoz, L.3
  • 25
    • 0027458051 scopus 로고
    • Insulin resistance and insulin deficiency in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: Errors of metabolism or methods?
    • Groop LC, Widén E E, Ferrannini E. Insulin resistance and insulin deficiency in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: errors of metabolism or methods? Diabetologia. 36:1993;1326-1331.
    • (1993) Diabetologia. , vol.36 , pp. 1326-1331
    • Groop, L.C.1    Widén, E.E.2    Ferrannini, E.3
  • 26
    • 0027180306 scopus 로고
    • Insulin and atherosclerosis: Villain, accomplice, or innocent bystander?
    • Savage PJ. Insulin and atherosclerosis: villain, accomplice, or innocent bystander? Br Heart J. 69:1993;473-475.
    • (1993) Br Heart J. , vol.69 , pp. 473-475
    • Savage, P.J.1
  • 27
    • 0027968932 scopus 로고
    • Why is insulin not a risk factor for coronary heart disease?
    • Jarrett RJ. Why is insulin not a risk factor for coronary heart disease? Diabetologia. 37:1994;945-947.
    • (1994) Diabetologia. , vol.37 , pp. 945-947
    • Jarrett, R.J.1
  • 28
    • 0029363997 scopus 로고
    • Associations between insulin levels and cardiovascular disease are confounded by comorbidity
    • McKeigue P, Davey G. Associations between insulin levels and cardiovascular disease are confounded by comorbidity. Diabetes Care. 18:1995;1294-1298.
    • (1995) Diabetes Care. , vol.18 , pp. 1294-1298
    • McKeigue, P.1    Davey, G.2
  • 30
    • 0030025673 scopus 로고    scopus 로고
    • Hypertension and associated metabolic abnormalities - The role of insulin resistance and the sympathoadrenal system
    • Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities - The role of insulin resistance and the sympathoadrenal system. NEJM. 334:1996;374-381.
    • (1996) NEJM. , vol.334 , pp. 374-381
    • Reaven, G.M.1    Lithell, H.2    Landsberg, L.3
  • 31
    • 0345716475 scopus 로고
    • Chronic hyperinsulinemia is a cause of insulin resistance for both glucose and protein metabolism
    • Battezzati A, Teruzzi I, Perseghin G, et al. Chronic hyperinsulinemia is a cause of insulin resistance for both glucose and protein metabolism. Horm Metab Res. 27:1995;60.
    • (1995) Horm Metab Res. , vol.27 , pp. 60
    • Battezzati, A.1    Teruzzi, I.2    Perseghin, G.3
  • 32
    • 0030027671 scopus 로고    scopus 로고
    • Persistent elevation of plasma insulin levels is associated with increased cardiovascular risk in children and young adults. The Bogalusa Heart Study
    • Bao W, Srinivasan SR, Berenson GS. Persistent elevation of plasma insulin levels is associated with increased cardiovascular risk in children and young adults. The Bogalusa Heart Study. Circulation. 93:1996;54-59.
    • (1996) Circulation. , vol.93 , pp. 54-59
    • Bao, W.1    Srinivasan, S.R.2    Berenson, G.S.3
  • 33
    • 0027370108 scopus 로고
    • The effect of intensive diabetes treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus
    • The effect of intensive diabetes treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus. NEJM. 329:1993;977-986.
    • (1993) NEJM. , vol.329 , pp. 977-986
  • 34
    • 0028817815 scopus 로고
    • U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: A progressive disease
    • U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: A progressive disease. Diabetes. 44:1995;1249-1258.
    • (1995) Diabetes. , vol.44 , pp. 1249-1258
  • 35
    • 0001173389 scopus 로고    scopus 로고
    • Clinical pharmacology of biguanides
    • J. Kuhlmann, Puls W. Berlin: Springer
    • Hermann LS. Clinical pharmacology of biguanides. Kuhlmann J, Puls W. Handbook of Experimental Pharmacology. 119:1996;373-407 Springer, Berlin.
    • (1996) Handbook of Experimental Pharmacology , vol.119 , pp. 373-407
    • Hermann, L.S.1
  • 36
    • 0026754428 scopus 로고
    • Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience)
    • Assmann G, Schulte H. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Am J Cardiol. 70:1992;733-737.
    • (1992) Am J Cardiol. , vol.70 , pp. 733-737
    • Assmann, G.1    Schulte, H.2
  • 37
    • 0027939375 scopus 로고
    • Plasma triglycerides and three lipoprotein cholesterol fractions are independent predictors of the extent of coronary atherosclerosis
    • Drexel H, Amann FW, Beran J, et al. Plasma triglycerides and three lipoprotein cholesterol fractions are independent predictors of the extent of coronary atherosclerosis. Circulation. 90:1994;2230-2235.
    • (1994) Circulation. , vol.90 , pp. 2230-2235
    • Drexel, H.1    Amann, F.W.2    Beran, J.3
  • 38
    • 0025878878 scopus 로고
    • Beneficial effects on serum lipids in non-insulin-dependent diabetics by acarbose treatment
    • Leonhardt W, Hanefeld M, Fischer S, et al. Beneficial effects on serum lipids in non-insulin-dependent diabetics by acarbose treatment. Drug Res. 41:1991;735-738.
    • (1991) Drug Res. , vol.41 , pp. 735-738
    • Leonhardt, W.1    Hanefeld, M.2    Fischer, S.3
  • 39
    • 0001540692 scopus 로고
    • Efficacy of acarbose in hyperinsulinemia and hyperlipidemia of obesity
    • Maruhama Y, Sasaki M, Ninomiya K, et al. Efficacy of acarbose in hyperinsulinemia and hyperlipidemia of obesity. Clin Rep (Japan). 29:1995;173-180.
    • (1995) Clin Rep (Japan). , vol.29 , pp. 173-180
    • Maruhama, Y.1    Sasaki, M.2    Ninomiya, K.3
  • 40
    • 0345284826 scopus 로고
    • Clinical studies on the parameters of lipid metabolism in patients with different types of diabetes mellitus
    • W. Creutzfeld. Amsterdam: Excerpta Medica
    • Marx W, Thomsen P, Ravens K-G. Clinical studies on the parameters of lipid metabolism in patients with different types of diabetes mellitus. Creutzfeld W. First International Symposium on Acarbose. 1982;380-384 Excerpta Medica, Amsterdam.
    • (1982) First International Symposium on Acarbose , pp. 380-384
    • Marx, W.1    Thomsen, P.2    Ravens K-G3
  • 41
    • 0020354048 scopus 로고
    • A prospective study of the effect of 12 months treatment on serum lipids and apolipoproteins A-I and B in type 2 (non-insulin-dependent) diabetes
    • Taylor KG, John WG, Mathews KA, Wright AD. A prospective study of the effect of 12 months treatment on serum lipids and apolipoproteins A-I and B in type 2 (non-insulin-dependent) diabetes. Diabetologia. 23:1982;507-510.
    • (1982) Diabetologia. , vol.23 , pp. 507-510
    • Taylor, K.G.1    John, W.G.2    Mathews, K.A.3    Wright, A.D.4
  • 42
    • 0025313775 scopus 로고
    • Comparison of tolbutamide and metformin in elderly diabetic patients
    • Josephkutty S, Potter JM. Comparison of tolbutamide and metformin in elderly diabetic patients. Diabet Med. 7:1990;510-514.
    • (1990) Diabet Med. , vol.7 , pp. 510-514
    • Josephkutty, S.1    Potter, J.M.2
  • 43
    • 0025903612 scopus 로고
    • Comparative three-month study of the efficacies of metformin and gliclazide in the treatment of NIDD
    • Noury J, Nandeuil A. Comparative three-month study of the efficacies of metformin and gliclazide in the treatment of NIDD. Diabet Metab. 17:1991;209-212.
    • (1991) Diabet Metab. , vol.17 , pp. 209-212
    • Noury, J.1    Nandeuil, A.2
  • 44
    • 0025873686 scopus 로고
    • Prospective comparative study in NIDDM patients of metformin and glibenclamide with special reference to lipid profiles
    • Hermann LS, Karlsson J-E, Sjöstrand É. Prospective comparative study in NIDDM patients of metformin and glibenclamide with special reference to lipid profiles. Eur J Clin Pharmacol. 41:1991;263-265.
    • (1991) Eur J Clin Pharmacol. , vol.41 , pp. 263-265
    • Hermann, L.S.1    Karlsson J-E2    Sjöstrand, É.3
  • 45
    • 0028605970 scopus 로고
    • One year comparative trial of metformin and glipizide in type 2 diabetes mellitus
    • Campbell IW, Menzies DG, Chalmers J, et al. One year comparative trial of metformin and glipizide in type 2 diabetes mellitus. Diabete Metab. 21:1994;394-400.
    • (1994) Diabete Metab. , vol.21 , pp. 394-400
    • Campbell, I.W.1    Menzies, D.G.2    Chalmers, J.3
  • 46
    • 0028798236 scopus 로고
    • Wirksamkeit und Verträglichkeit von einschleichend dosierter Acarbose bei Patienten mit einem nicht insulinpflichtigen Diabetes mellitus (NIDDM) unter Sulfonylharnstofftherapie
    • May C. Wirksamkeit und Verträglichkeit von einschleichend dosierter Acarbose bei Patienten mit einem nicht insulinpflichtigen Diabetes mellitus (NIDDM) unter Sulfonylharnstofftherapie. Diabetes Stoffw. 4:1995;3-8.
    • (1995) Diabetes Stoffw. , vol.4 , pp. 3-8
    • May, C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.